Compound Summary
Compound Name: | Alinidine |
Compound CID: | 36354 |
Synonyms: | Alinidine 33178-86-8 ST-567 2-(N-Allyl-2,6-dichloroanilino)-2-imidazoline UNII-E7IDJ8DS1D More... |
Iupac Name: | N-(2,6-dichlorophenyl)-N-prop-2-enyl-4,5-dihydro-1H-imidazol-2-amine |
InChI: | InChI=1S/C12H13Cl2N3/c1-2-8-17(12-15-6-7-16-12)11-9(13)4-3-5-10(11)14/h2-5H,1,6-8H2,(H,15,16) |
InChIKey: | OXTYVEUAQHPPMV-UHFFFAOYSA-N |
Canonical Smiles: | C=CCN(C1=C(C=CC=C1Cl)Cl)C2=NCCN2 |
Isomeric Smiles: | C=CCN(C1=C(C=CC=C1Cl)Cl)C2=NCCN2 |
Molecular Weight: | 270.15 |
Molecular Formula: | C12H13Cl2N3 |
Molecular Weight: | 270.15 |
Molecular Formula: | C12H13Cl2N3 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 1 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 17 |
Complexity: | 296 |
Alinidine | Alinidine |
---|---|
Alinidine |
33178-86-8 |
ST-567 |
2-(N-Allyl-2,6-dichloroanilino)-2-imidazoline |
UNII-E7IDJ8DS1D |
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-N-2-propenyl- |
2-(N-Allyl-N-(2,6-dichlorophenyl)amino)-2-imidazoline |
E7IDJ8DS1D |
Alinidin |
ST 567-BR AS HYDROBROMIDE |
2-IMIDAZOLINE, 2-(N-ALLYL-2,6-DICHLOROANILINO)- |
NCGC00162175-01 |
N-Allyl-N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine |
Alinidinum |
Alinidina |
Alinidinum INN-Latin |
Alinidina INN-Spanish |
Alinidine INN:BAN |
BRN 0961200 |
Allindine |
DSSTox_CID_2571 |
DSSTox_RID_76635 |
DSSTox_GSID_22571 |
5-25-09-00280 (Beilstein Handbook Reference) |
SCHEMBL828946 |
CHEMBL278581 |
ZINC3723 |
DTXSID4022571 |
BDBM85231 |
ST-567-BR |
Tox21_112002 |
N-(2,6-dichlorophenyl)-N-prop-2-enyl-4,5-dihydro-1H-imidazol-2-amine |
LP00514 |
SDCCGSBI-0633723.P001 |
NCGC00162175-02 |
NCGC00162175-03 |
CAS-33178-86-8 |
CAS_33178-86-8 |
FT-0713597 |
J-019070 |
Q4726779 |
2-N-allyl-N-(2,6-dichloro-phenyl)-amino-2-imidazoline |
N-Allyl-N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine # |
N-(2,6-dichlorophenyl)-N-prop-2-en-1-yl-4,5-dihydro-1H-imidazol-2-amine |
Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33 | umol/L | 6 | NS | N2 | 24134630 | Inactive |
Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 6 | 1 | 1 |